Benzimidamide Antimicrobial Synthesis via One-Pot Catalysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a growing need for new antimicrobial agents effective against drug-resistant microorganisms, and existing methods face challenges in synthesizing therapeutically active compounds with high yields without solvents, efficient reaction times, and recyclable catalysts, particularly in the context of the 1,3,4-oxadiazole nucleus and amidine functional group.
Innovation Solution
A 4-chloro-N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide compound is synthesized via a one-pot three-component reaction using carbonyldiimidazole as a catalyst in acetonitrile, demonstrating excellent antimicrobial activity against various microbes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotic methods are used, then treatment of bacterial infections is achieved, but effectiveness decreases due to increasing drug resistance
Solution Approach 1:
The patent introduces a novel chemical compound with a specific molecular structure (4-chloro-N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide) that combines a 1,3,4-oxadiazole nucleus with an amidine functional group. This structural parameter change creates a new chemical entity with different biological properties, enabling it to overcome resistance mechanisms that have developed against conventional antibiotics.
2Reliability
If complex synthesis methods are used to create new antimicrobial agents, then therapeutic activity is improved, but synthesis difficulty and time increase
Solution Approach 1:
The patent employs a one-pot three-component reaction that combines 2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetic acid, 4-chloro-N′-hydroxybenzene-1-carboximidamide, and carbonyldiimidazole (CDI) catalyst in a single reaction vessel. This merging of multiple reaction steps into one process achieves satisfactory yields (average about 68%) while significantly reducing synthesis time and operational complexity.
Solution Approach 2:
The use of carbonyldiimidazole (CDI) as a catalyst changes the reaction parameters by providing an alternative reaction pathway with lower activation energy. This catalytic approach enables the synthesis to proceed under milder conditions with shorter reaction times while maintaining high yields, thus improving productivity without sacrificing therapeutic activity.
3Ease of manufacture
If traditional synthesis procedures are used, then compound production is achieved, but solvent use and environmental impact increase
Solution Approach 1:
The patent employs acetonitrile as a solvent that can be easily evaporated and removed from the reaction mixture. The solvent is used in a controlled amount and can be completely eliminated through standard evaporation techniques, leaving no residual contamination in the final product. This approach minimizes solvent consumption and environmental impact while maintaining synthesis feasibility.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound achieves high yields (about 68%) and exhibits strong antimicrobial activity against gram-positive and gram-negative bacteria, as well as fungi, providing a promising therapeutic option for microbial infections.
Implementation Method 1
using carbonyldiimidazole (CDI) as a catalyst
Data Source
AI summary
A 4-chloro-N′-(2-(5-phenyl-1,3,4-oxadiazol-2-ylthio)acetoxy)benzimidamide compound, its synthesis, and its use as an antimicrobial agent.